Clinical trial
Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria
NCT02576041 is registered in ClinicalTrials.gov with Menarini International Operations Luxembourg SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria
- Lead sponsor
- Menarini International Operations Luxembourg SA
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- December 31, 2015
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic rhinitis, urticaria